|
SGK196 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.463880E-03 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
7.757700E-04 |
| Normal-vs-Stage2 |
4.354400E-02 |
| Normal-vs-Stage3 |
7.064600E-01 |
| Normal-vs-Stage4 |
6.503200E-01 |
| Stage1-vs-Stage2 |
5.155400E-01 |
| Stage1-vs-Stage3 |
9.517600E-02 |
| Stage1-vs-Stage4 |
5.188600E-01 |
| Stage2-vs-Stage3 |
3.063000E-01 |
| Stage2-vs-Stage4 |
7.097200E-01 |
| Stage3-vs-Stage4 |
8.050200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
6.988200E-04 |
| Normal-vs-AfricanAmerican |
4.162500E-03 |
| Normal-vs-Asian |
4.175600E-03 |
| Caucasian-vs-AfricanAmerican |
9.711400E-01 |
| Caucasian-vs-Asian |
3.245200E-01 |
| AfricanAmerican-vs-Asian |
3.265400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.7951000000036E-05 |
| Normal-vs-Female |
9.361000E-01 |
| Male-vs-Female |
1.100960E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
9.648400E-02 |
| Normal-vs-Extreme_Weight |
3.1139000000735E-07 |
| Normal-vs-Obese |
1.824780E-01 |
| Normal-vs-Extreme_Obese |
4.822200E-03 |
| Normal_Weight-vs-Extreme_Weight |
7.305900E-02 |
| Normal_Weight-vs-Obese |
6.276200E-01 |
| Normal_Weight-vs-Extreme_Obese |
2.393200E-01 |
| Extreme_Weight-vs-Obese |
4.820400E-03 |
| Extreme_Weight-vs-Extreme_Obese |
7.278400E-01 |
| Obese-vs-Extreme_Obese |
7.053700E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
9.607000E-01 |
| Normal-vs-Age(41-60Yrs) |
2.662400E-02 |
| Normal-vs-Age(61-80Yrs) |
2.16060000000073E-05 |
| Normal-vs-Age(81-100Yrs) |
5.785500E-04 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.163200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.512560E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.641900E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.184100E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.256300E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.100200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
4.3141999999996E-05 |
| Normal-VS-Type2 PRCC |
1.286230E-02 |
| Normal-VS-KIRP CIMP |
2.923600E-01 |
| Normal-VS-Unclassified PRCC |
4.327800E-01 |
| Type1 PRCC-VS-Type2 PRCC |
1.216580E-01 |
| Type1 PRCC-VS-KIRP CIMP |
6.696200E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
2.403500E-02 |
| Type2 PRCC-VS-KIRP CIMP |
1.134030E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
2.347600E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
2.072200E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
8.394900E-04 |
| Normal-vs-N1 |
7.695200E-01 |
| Normal-vs-N2 |
9.584400E-01 |
| N0-vs-N1 |
5.679700E-02 |
| N0-vs-N2 |
5.666000E-01 |
| N1-vs-N2 |
9.592800E-01 |
|
|
